22 January 2025
ANANDA PHARMA PLC
("Ananda" or the "Company")
Webinar Presentation
Ananda Pharma plc (AQSE: ANA), a Company focused on the the development of cannabinoid based therapies for the treatment of a range of complex conditions, is pleased to announce that to kick off 2025, Melissa Sturgess, CEO, will provide a live update presentation and Q&A session via the Company's InvestorHub on Wednesday, 29 January 2025, at 12:30 GMT.
The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via the webinar page up until 27 January 2025, 12:30 GMT, or at any time during the live presentation.
Investors can sign up to the webinar for free via: https://investors.anandapharma.co.uk/webinars/LeoVy6-2025-kick-off
To stay abreast of the latest developments at Ananda, we encourage you to follow our social media channels which are:
· Investor Hub: https://investors.anandapharma.co.uk/s/ea8f93
· Instagram: https://www.instagram.com/anandapharmaplc/
· LinkedIn: https://www.linkedin.com/company/anandapharma
· X: https://twitter.com/AnandaPlc
· Investor Meet Company: https://www.investormeetcompany.com/ananda-pharma-plc/register-investor
-Ends-
The Directors of the Company accept responsibility for the contents of this announcement.
| ANANDA PHARMA PLC | +44 (0)7463 686 497 |
|
| |
| |
|
| Chief Executive Officer | |
| Melissa Sturgess | |
| | |
| Finance Director | |
| Jeremy Sturgess-Smith | |
| | |
| SP ANGEL CORPORATE FINANCE LLP | +44 (0)20 3470 0470 |
| | |
| Corporate Finance | |
| Richard Morrison | |
| | |
| | |
| Corporate Broking | |
| Abigail Wayne | |
| Rob Rees
| |
|
Yellow Jersey PR (media enquiries) Sarah MacLeod Charles Goodwin Zara McKinlay |
+44 (0)20 3004 9512 ananda@yellowjerseypr.com |
About Ananda Pharma
Ananda is an AQSE-listed life sciences company focused on the research and clinical development of cannabinoid therapies for a range of complex conditions.
For more information, please visit: www.anandapharma.co.uk
https://investors.anandapharma.co.uk/link/DexQwr
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
